SCHEMBL3385250

SCHEMBL3385250

CS(=O)(=O)c1ccc(-c2ccn3c(-c4ccc(CC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cnc3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 7/20 0.47
DDR1 Q08345 1/20 0.44
RORC P51449 1/20 0.44
KDR P35968 7/20 0.42
FGFR3 P22607 2/20 0.41
CSF1R P07333 2/20 0.41
NTRK1 P04629 1/20 0.41
RET P07949 1/20 0.41
KCNH2 Q12809 1/20 0.41
CCDC6 Q16204 1/20 0.41
TEK Q02763 1/20 0.40
PTGS2 P35354 1/20 0.40
RIPK1 Q13546 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385476 0.89 KDR (0.49) FLT3DDR1KDRFGFR3CSF1R
SCHEMBL3385413 0.86 RORC (0.48) FLT3RORCKDRFGFR3CSF1R
SCHEMBL3383213 0.86 RET (0.55) FLT3KDRFGFR3RETPTGS2
SCHEMBL3185028 0.81 BACE1 (0.49) FLT3KDRFGFR3
SCHEMBL27705869 0.81 KDR (0.49) FLT3KDRFGFR3
SCHEMBL3385738 0.80 FLT3 (0.49) FLT3RORCKDRFGFR3
SCHEMBL3380684 0.79 EPHX2 (0.53) FLT3KDRFGFR3
SCHEMBL3195685 0.79 KDR (0.54) FLT3KDRFGFR3RET
SCHEMBL3383453 0.77 FLT3 (0.53) FLT3KDRCSF1RNTRK1RET
SCHEMBL3386505 0.77 RET (0.65) FLT3KDRCSF1RNTRK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128461-B Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors LILLY CO ELI 2010-12-22 CN disclosed
EP-1904494-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS LILLY CO ELI (US) 2010-12-01 EP disclosed
CN-101128461-A Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors LILLY CO ELI (US) 2008-02-20 CN disclosed